alexa
Reach Us +44-1625-708989
Killer B Cells And Their Exosomes In Immune Tolerance | 4321
ISSN: 2161-0959

Journal of Nephrology & Therapeutics
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Killer B cells and their exosomes in immune tolerance

International Conference and Exhibition on Nephrology & Therapeutics

Steven K. Lundy

ScientificTracks Abstracts: J Nephrol Therapeut

DOI: 10.4172/2161-0959.S1.004

Abstract
T he active induction of immune tolerance by specialized molecules and cells is critical in protection against autoimmune diseases and is a therapeutic target in solid organ transplantation. Killer B lymphocytes are a small subset of immune cells that express the death-inducing ligand, FasL, and that mediate cell death of antigen-specific CD4+ T cells. FasL+ B cells were shown to be necessary for a donor-specific transfusion (DST) response which promoted the survival of male to female skin grafts in mice. DST has also been reported to be effective at inducing immune tolerance in clinical trials of MHC-mismatched heart and kidney transplants. Our laboratory has focused on the biology of killer B cells with emphasis on the expression of FasL and their interactions with T cells. FasL+ B cells are present in spleens of unimmunized mice and have markers similar to other immune suppressive subsets of B cells. FasL+ B cells express high levels of IL-5 receptor and grow in response to IL-5 stimulation in cell culture. Cultured killer B cells induce apoptosis of activated CD4+ T cells by an antigen-specific and FasL-dependent mechanism. Killer B cells produce FasL+ ?lethal? exosomes, subcellular vesicles that also express MHC Class II and are capable of inducing antigen-specific T cell death. Together, these properties of killer B cells make them attractive new targets for establishing immune tolerance in the clinical setting of autoimmune disease treatment and solid organ transplantation.
Biography
Steven K. Lundy, Ph.D. is a Research Assistant Professor in Internal Medicine-Rheumatology at the University of Michigan Medical School in Ann Arbor. Steve grew up in central Wisconsin and northern Michigan and earned his Bachelor?s degree in Biochemistry from Oakland University in 1987. He worked as a research technician for ten years at the Mayo Clinic and Wayne State University and then earned his doctorate in Immunology and Microbiology from Wayne State in 2001. His work for the past decade has focused on killer B cells in chronic inflammatory conditions ranging from schistosome worm infection to asthma and autoimmune diseases
Relevant Topics
Top